Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina Inc
(NQ:
ILMN
)
121.10
+4.74 (+4.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Illumina Inc
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
92 Biggest Movers From Friday
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...
Via
Benzinga
Illumina Reports 41% Dip In Q1 Profits Despite 12% Jump in Sales, Reaffirms FY22 Guidance
May 06, 2022
Via
Benzinga
Illumina Crushes Earnings Forecast, Though Sales Only Meet Expectations
May 05, 2022
The next-generation DNA sequencing company expects double-digit 2022 sales growth.
Via
Investor's Business Daily
Analyst Ratings For Illumina
March 29, 2022
Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter:
Via
Benzinga
If You Invested $1000 In Ilumina 10 Years Ago, Here's How Much You Would Have Today
May 06, 2022
Illumina (NASDAQ:ILMN) has outperformed the market over the past 10 years by 7.06% on an annualized basis producing an average annual return of 18.79%. Currently, Illumina has a market capitalization...
Via
Benzinga
55 Stocks Moving In Friday's Mid-Day Session
May 06, 2022
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
Via
Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
May 02, 2022
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...
Via
Benzinga
Markets Pare Early Losses As Musk-Twitter Agree On Buyout Deal
April 25, 2022
U.S. indices pared early losses and closed higher Monday. Markets were trading lower to start the session as stocks continued to fall after the Fed last week indicated it may move...
Via
Benzinga
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
April 20, 2022
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was...
Via
Benzinga
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
April 16, 2022
Let’s pause to consider earlier attempts at hostile takeovers by well-respected and well-financed entities and individuals that — to ransack some Musk-worthy clichés — took off like a rocket ship but...
Via
Talk Markets
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
April 15, 2022
As any student of industry knows, Elon Musk is hardly the first person to attempt a hostile takeover.
Via
Benzinga
Illumina's Q4 Profit Falls Despite Topline Growth Of 26%
February 11, 2022
Illumina Inc (NASDAQ: ILMN) reported
Via
Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 5 Years
April 06, 2022
Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 1.75% on an annualized basis producing an average annual return of 15.45%. Currently, Illumina has a market capitalization of...
Via
Benzinga
3 Top S&P 500 Stock Market Gainers Today: Medicals Lead As This Sector Reverses Hard
April 01, 2022
Medical and gold stocks led the S&P 500. Transport stocks were big losers.
Via
Investor's Business Daily
April Fool
April 01, 2022
Today China pushed its iron ore price to an 8 month high to help pay for pricey oil and gas.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
March 29, 2022
Upgrades
Via
Benzinga
Illumina Launches Multiple-Gene Diagnostic Test For Cancer Patients
March 15, 2022
Illumina Inc (NASDAQ: ILMN) has launched TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the...
Via
Benzinga
CNBC's Final Trades: iShares MSCI UK, Illumina, US Silica And This Company That Has An Attractive Buyout Deal
February 27, 2022
On CNBC’s “Halftime Report...
Via
Benzinga
Bionano Stock Looks to Have a Monster Comeback in Its Future
February 17, 2022
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.
Via
InvestorPlace
Give peace a chance
February 15, 2022
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.
Via
Talk Markets
Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More
February 12, 2022
This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to...
Via
Benzinga
Dominion Energy, Under Armour, And Expedia Among Another Slew Of Earnings Reports
February 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Friday Market Open) Equity index...
Via
Benzinga
Expert Ratings For Illumina
February 11, 2022
Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
10 Biggest Price Target Changes For Friday
February 11, 2022
SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading.
Via
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Thursday's Plunge
February 11, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. Investors are awaiting earnings...
Via
Benzinga
5 Stocks To Watch For February 11, 2022
February 11, 2022
Some of the stocks that may grab investor focus today are:
Via
Benzinga
Illumina: Q4 Earnings Insights
February 10, 2022
Illumina (NASDAQ:ILMN) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Illumina beat estimated earnings...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.